IL-13, a T helper type 2
cytokine, is reported to be increased in the tissue of patients with
atopic dermatitis (AD). In addition, chronic lichenified plaques in AD show thickened epidermis and dermis. We hypothesized that
IL-13 is involved in tissue remodeling by altering the expression of
matrix metalloproteinases (
MMPs). In this study, we examined the
MMP-related genes targeted by
IL-13 in human dermal fibroblasts using a
complementary DNA microarray. We focused on the MMP-13 gene, which was identified as one of the
MMPs suppressed by
IL-13.
IL-13 downregulated both MMP-13
protein and
mRNA expression.
IL-13 suppressed MMP-13 expression more effectively in the presence of
protein kinase C (PKC)-δ inhibitor, whereas
IL-13 upregulated MMP-13 in the presence of inhibitors of
phosphoinositide 3-kinase (PI3K)/Akt pathway or Akt3-specific
small interfering RNA. Our results suggest that MMP-13 expression is negatively controlled by PI3K/Akt3 and positively regulated by PKC-δ in the presence of
IL-13. Taken together, these findings indicate that
IL-13 may induce the formation of thickened dermis in AD by decreasing
collagen degradation. Blockade of
IL-13 signaling cascades in AD patients may be a new therapeutic approach.